Ko U. Min

FDA investigator

Appears on 13 documents from 2017 to 2023, mostly at sites in New Jersey. Most often cites general requirements (21 CFR 211.160).

13
Documents on file
8.0
Observations per 483
2017
First seen
2023
Most recent

What they cite most

From 103 observations

Activity by year

2017: 2, 2018: 2, 2020: 3, 2021: 2, 2022: 3, 2023: 1

Where

New Jersey 9 · Pennsylvania 2 · Maryland 1 · West Virginia 1

Is Ko U. Min coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

13 documents, newest first
FirmOpen
483 PEL Healthcare LLCJan 13, 2023 · Sellersville, Pennsylvania
483 Akorn Operating Company LLC (dba Akorn)May 17, 2022 · Somerset, New Jersey
483 Novel Laboratories , Inc. d.b . a Lupin Somerset 'Mar 30, 2022 · Somerset, New Jersey
483 Guardian Drug Co. IncFeb 17, 2022 · Dayton, New Jersey
483 Aurolife Pharma LLCDec 7, 2021 · Dayton, New Jersey
483 Carnegie Pharmaceuticals, LLCJun 29, 2021 · Delran, New Jersey
483 Novel Laboratories, Inc.Nov 5, 2020 · Somerset, New Jersey

About this profile

What does Ko U. Min inspect?

Ko U. Min appears on 13 documents on file covering 11 sites, mostly in New Jersey.

What do they cite most often?

21 CFR 211.160 (general requirements), followed by 21 CFR 211.192 and 21 CFR 211.67.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Ko U. Min is dated Jan 13, 2023.

FDA Investigator Ko U. Min: 483s & Inspections · FDA Intel